Cargando…

Immunoglobulin levels and infection risk with rituximab induction for anti-neutrophil cytoplasmic antibody-associated vasculitis

BACKGROUND: Rituximab (RTX), a B cell–depleting anti-CD20 monoclonal antibody, is approved for treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Low immunoglobulin (Ig) levels have been observed surrounding RTX treatment. The association between the degree of Ig d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Shivani, Jaggi, Khushleen, Greenberg, Keiko, Geetha, Duvuru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Rituximab
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570101/ https://www.ncbi.nlm.nih.gov/pubmed/28852483 http://dx.doi.org/10.1093/ckj/sfx014

Ejemplares similares

Infectious complications of rituximab therapy in renal disease
por: Nixon, Andrew, et al.
Publicado: (2017)

Infectious complications of a rituximab-based immunosuppressive regimen in patients with glomerular disease
por: Trivin, Claire, et al.
Publicado: (2017)

Impact of rituximab on humoral response to COVID-19 booster vaccine and antibody kinetics in patients with anti–neutrophil cytoplasmic antibody vasculitis
por: Kant, Sam, et al.
Publicado: (2021)

Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti–neutrophil cytoplasmic antibody–associated vasculitis
por: Kant, Sam, et al.
Publicado: (2022)

Tixagevimab and Cilgavimab (Evusheld) in Rituximab-treated Antineutrophil Cytoplasmic Antibody Vasculitis Patients
por: Aqeel, Faten, et al.
Publicado: (2022)

Practice Patterns of Induction Therapy in Severe Anti-neutrophil Cytoplasmic Autoantibody-Associated Vasculitis
por: Aqeel, Faten, et al.
Publicado: (2022)

Subcutaneous Immunoglobulin for Antibody Deficiency in Antineutrophil Cytoplasmic Antibody (ANCA)-associated Vasculitis
por: Kant, Sam, et al.
Publicado: (2019)

Repeat Kidney Biopsies in Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis: Clinical and Histologic Progression
por: Aqeel, Faten, et al.
Publicado: (2023)

Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis
por: Shah, Shivani, et al.
Publicado: (2015)

Eosinophils in anti-neutrophil cytoplasmic antibody associated vasculitis
por: Hellmark, Thomas, et al.
Publicado: (2019)

Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Sun, Xiao-Jing, et al.
Publicado: (2023)

Characteristics and Outcomes of COVID-19 in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: Kant, Sam, et al.
Publicado: (2020)

Rituximab in Combination with Corticosteroids for the Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A NICE Single Technology Appraisal
por: Latimer, Nicholas R., et al.
Publicado: (2014)

Recent advances in anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Lazarus, B., et al.
Publicado: (2016)

Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)–Associated Vasculitis
por: Salama, Alan D.
Publicado: (2019)

Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Weng, Cheng-Hua, et al.
Publicado: (2019)

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Kidney Transplantation
por: Binda, Valentina, et al.
Publicado: (2021)

Bamlanivimab Decreases Severe Outcomes of SARS-CoV-2 Infection in Patients With Antineutrophil Cytoplasmic Antibody Vasculitis
por: Ghosh, Jyotsna, et al.
Publicado: (2021)

Rituximab-associated hypogammaglobulinemia in ANCA-associated vasculitis: Incidence and time course
por: Tariq, Anam, et al.
Publicado: (2022)

Long-term Clinical Course of Antineutrophil Cytoplasmic Antibody-associated Vasculitis Patients off Maintenance Therapy
por: Gapud, Eric J, et al.
Publicado: (2018)

Comparisons of Guidelines and Recommendations on Managing Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: Geetha, Duvuru, et al.
Publicado: (2018)

Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis
por: McAdoo, Stephen P, et al.
Publicado: (2019)

Posterior scleritis with anti-neutrophil cytoplasmic antibody-associated vasculitis utilizing rituximab therapy to maintain remission: A case report
por: Weng, Xinyu, et al.
Publicado: (2022)

Ectopic Relapse of Anti-neutrophil Cytoplasmic Antibody-associated Pituitary Vasculitis with No Elevation of Anti-neutrophil Cytoplasmic Antibodies after Renal Remission
por: Muto, Reiko, et al.
Publicado: (2020)

Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Robson, Joanna C., et al.
Publicado: (2017)

Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis (AAV) Restricted to the Limbs
por: Ojima, Yoshie, et al.
Publicado: (2017)

Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody（ANCA）-associated vasculitis
por: Tsukui, Daisuke, et al.
Publicado: (2021)

Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
por: Wu, Haiting, et al.
Publicado: (2022)

Slo-Mo anti-neutrophil cytoplasmic antibody-associated renal vasculitis
por: Avello, Alejandro, et al.
Publicado: (2020)

Tozinameran: Anti neutrophil cytoplasmic antibody-associated vasculitis: case report
Publicado: (2022)

A glance into the future of anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Casal Moura, Marta, et al.
Publicado: (2022)

Hydralazine-Induced Anti-neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
por: Echevarria, Victoria, et al.
Publicado: (2023)

Highly Sensitive Flow Cytometric Detection of Residual B-Cells After Rituximab in Anti-Neutrophil Cytoplasmic Antibodies-Associated Vasculitis Patients
por: van Dam, Laura S., et al.
Publicado: (2020)

Patient Outcomes in Renal-Limited Antineutrophil Cytoplasmic Antibody Vasculitis With Inactive Histology
por: Novick, Tessa K., et al.
Publicado: (2018)

Comparison of Two Rituximab Induction Regimens for Antineutrophil Cytoplasm Antibody–Associated Vasculitis: Systematic Review and Meta‐Analysis
por: Bénard, Valérie, et al.
Publicado: (2021)

Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: Thietart, Sara, et al.
Publicado: (2022)

Azathioprine hypersensitivity syndrome in anti-myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Greite, Robert, et al.
Publicado: (2018)

Azathioprine hypersensitivity syndrome in anti-myeloperoxidase anti-neutrophil cytoplasmic antibody-associated vasculitis
por: Greite, Robert, et al.
Publicado: (2018)

Improvement of Alveolar Hemorrhaging in an Elderly and Renally Impaired Patient with Relapsing Anti-neutrophil Cytoplasmic Autoantibody-associated Vasculitis by Single Infusion of Rituximab
por: Oda, Keiko, et al.
Publicado: (2018)

Testicular granulomatous vasculitis mimicking testicular torsion in an anti-neutrophil cytoplasmic antibody–associated vasculitis patient
por: Suo, Liye, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_km6roclek61un67vd9f9neqabh